Receive our newsletter – data, insights and analysis delivered to you
June 30, 2009

Indian Pharmaceutical Company Takes SA Treasury to Court

India's Aurobindo is taking the South African Treasury to court claiming that it lost out unfairly on lucrative anti-retroviral (ARV) contracts. Aurobindo claims that it lost out on a $400m ARV contract to local South African companies despite tendering a cheaper price for the drugs.

By cms admin

India’s Aurobindo is taking the South African Treasury to court claiming that it lost out unfairly on lucrative anti-retroviral (ARV) contracts.

Aurobindo claims that it lost out on a $400m ARV contract to local South African companies despite tendering a cheaper price for the drugs.

A report by South African newspaper Business Day said that the tender award might have been influenced by a study compiled by the Industrial Development Corporation commissioned by the Department of Trade and Industry, which took into account the contribution back into the economy by local manufacturers versus overseas-based importers.

The court case over local bias puts pressure on bilateral agreements between the South African pharmaceutical industry and its counterparts in India.

According to Business Day neither company would comment as the case was sub judice.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU